Tag: chemotherapy industry growth

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Chemotherapy Market Evolve in Terms of Growth and Size by 2029?

In the past few years, the chemotherapy market has experienced robust growth. It is projected to grow from $34 billion in 2024, soaring to $37.27 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. Factors contributing to the growth during the historic period include increased cancer occurrences, advancements in cancer detection procedures, innovative drug development, clinical trial activity, improved healthcare access, and awareness campaigns.

The market size of chemotherapy is predicted to experience accelerated growth in the forthcoming years, increasing to $60.31 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 12.8%. The predicted growth during the forecast period can be credited to the incorporation of immunotherapy, adoption of biosimilars, expansion of emerging markets, genomic profiling, enhancements in supportive care, and regulatory facilitation. Significant trends anticipated during the forecast period include the use of digital health solutions, personalized medicine, persistent oncology research, assimilation of AI, progress in nanotechnology, and home-based chemotherapy administration.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

What factors are expected to fuel Chemotherapy market growth in the coming years?

The growth of the chemotherapy market is anticipated to be propelled by the escalating prevalence of cancer. Cancer is a condition where certain cells in the body grow uncontrollably and spread elsewhere. Chemotherapy involves the use of potent chemicals, either singularly or in a combination, to treat cancer by destroying rapidly growing cancer cells. This upward trend in the incidence of cancer is likely to spur the demand for chemotherapy. For example, the American Cancer Society Inc., a not-for-profit health organization based in America, predicts that the number of newly diagnosed cancer cases will rise to 1.9 million in 2023, compared to 1.8 million in 2020. Moreover, it is projected that by 2023, the number of cancer-related deaths will reach 609,820 in the US, rising from 606,520 in 2020. Consequently, the rising incidence of cancer is the driving force behind the expanding chemotherapy market.

What Are The Key Findings From The Segmentation Analysis Of The Chemotherapy Market?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

Which Trends Are Expected To Shape The Future Of The Chemotherapy Market?

Key players in the chemotherapy market are aiming to set themselves apart through the introduction of inventive products such as chemotherapy infusion pumps. These particular devices administer chemotherapy drugs directly into the blood via an intravenous line. The aim is to manage chemotherapy administration in a managed, slow and steady way, permitting a continuous and gradual drug infusion to the patient. One example is Shanghai MicroPort Lifesciences Co. Ltd., a Chinese medical technology producer; in March 2022, they were granted marketing approval from the National Medical Products Administration (NMPA) in China for their AutoEx Chemotherapy Infusion Pump. The AutoEx is engineered to either continuously or intermittently infuse chemotherapy drugs into patients dealing with malignancies. The ultimate goal is to maintain an ideal drug concentration in the patient’s bloodstream, which optimises the success of the cancer treatment and minimizes side effects. The pump is designed with a dual CPU control system and a backup power supply, allowing for outstanding precision in drug delivery – improving patient comfort and safety throughout chemotherapy.

What Are The Most Active Companies In The Chemotherapy Market Today?

Major companies operating in the chemotherapy market include GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Which Regional Markets Are Attracting The Most Investment In Chemotherapy?

North America was the largest region in the chemotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9219&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Chemotherapy Market Size Changed, over the years?

In the past few years, there has been a substantial growth in the market size of chemotherapy. It is anticipated to escalate from $34 billion in 2024 to $37.78 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.1%. The remarkable growth during the historical period can be ascribed to factors such as the rising incidence of cancer, the progress in the detection of cancer, the creation of innovative drugs, active clinical trials, ease of access to healthcare, and promotional campaigns for awareness.

How Much Will the Chemotherapy Market Be Worth in 2029?

Anticipations point towards a significant expansion of the chemotherapy market in the coming years. With a compound annual growth rate (CAGR) of 13.3%, the market is projected to escalate to $62.22 billion by 2029. The projected growth within this period can be traced to factors such as the incorporation of immunotherapy, the adoption of biosimilars, burgeoning markets, genomic profiling, advancements in supportive care and regulatory facilitation. Looming trends within this forecast period encompasses digital health solutions, personalized medicine, sustained research in oncology, the integration of artificial intelligence (ai), advancements in nanotechnology and the administration of chemotherapy at home.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

Which is the Largest Company in the Chemotherapy Market?

Major companies operating in the chemotherapy market include GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

What Are the Main Market Drivers in the Chemotherapy Industry?

The escalation in cancer incidences is anticipated to stimulate the expansion of the chemotherapy market. Cancer is a condition where some body cells proliferate uncontrollably and invade other areas. Chemotherapy employs potent chemicals, either singly or in a mix, to treat cancer by exterminating rapidly proliferating cancer cells. Moreover, the rise in cancer incidences will heighten the need for chemotherapy. For instance, the American Cancer Society Inc., a non-profit health organization based in the US, predicts that by 2023, there will be 1.9 million new cancer diagnoses in the US, a rise from the 1.8 million new cases diagnosed in 2020. There are projections of 609,820 cancer-related fatalities in the US in 2023, whilst 606,520 cancer deaths were projected for 2020. Thus, the escalating incidences of cancer are fueling the growth of the chemotherapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9219&type=smp

How Is the Chemotherapy Market Segments Structured?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

What Strategic Trends Are Transforming the Chemotherapy Market?

Leading corporations in the chemotherapy market are concentrating on bringing forth innovative products such as chemotherapy infusion pumps to solidify their position. These infusion pumps serve as a conduit for chemo drugs directly into the patient’s bloodstream via an IV line. It aids in the regulation of chemotherapy delivery in a controlled fashion, permitting a consistent, gradual introduction of drugs into the body. A case in point, in March 2022, Shanghai MicroPort Lifesciences Co. Ltd., a medical technology developer and manufacturer based in China, got the green light from the National Medical Products Administration (NMPA) of China to market its AutoEx Chemotherapy Infusion Pump. The pump is a design for the continuous or sporadic infusion of chemotherapy treatments for patients battling malignancies. Its function is to uphold the optimum drug concentration in the blood, thereby boosting the efficacy of the cancer treatment while minimizing side effects. The infusion pump boasts of a dual CPU control system and dual power supply, allowing the precise delivery of drugs and improving the patient’s comfort and safety during chemotherapy treatments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Which Global Regions Offer the Highest Growth in the Chemotherapy Market?

North America was the largest region in the chemotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9219

This Report Delivers Insight On:

1. How big is the chemotherapy market, and how is it changing globally?

2. Who are the major companies in the chemotherapy market, and how are they performing?

3. What are the key opportunities and risks in the chemotherapy market right now?

4. Which products or customer segments are growing the most in the chemotherapy market?

5. What factors are helping or slowing down the growth of the chemotherapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Chemotherapy Market Size Changed, over the years?

In the past few years, there has been a substantial growth in the market size of chemotherapy. It is anticipated to escalate from $34 billion in 2024 to $37.78 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.1%. The remarkable growth during the historical period can be ascribed to factors such as the rising incidence of cancer, the progress in the detection of cancer, the creation of innovative drugs, active clinical trials, ease of access to healthcare, and promotional campaigns for awareness.

How Much Will the Chemotherapy Market Be Worth in 2029?

Anticipations point towards a significant expansion of the chemotherapy market in the coming years. With a compound annual growth rate (CAGR) of 13.3%, the market is projected to escalate to $62.22 billion by 2029. The projected growth within this period can be traced to factors such as the incorporation of immunotherapy, the adoption of biosimilars, burgeoning markets, genomic profiling, advancements in supportive care and regulatory facilitation. Looming trends within this forecast period encompasses digital health solutions, personalized medicine, sustained research in oncology, the integration of artificial intelligence (ai), advancements in nanotechnology and the administration of chemotherapy at home.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

Which is the Largest Company in the Chemotherapy Market?

Major companies operating in the chemotherapy market include GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

What Are the Main Market Drivers in the Chemotherapy Industry?

The escalation in cancer incidences is anticipated to stimulate the expansion of the chemotherapy market. Cancer is a condition where some body cells proliferate uncontrollably and invade other areas. Chemotherapy employs potent chemicals, either singly or in a mix, to treat cancer by exterminating rapidly proliferating cancer cells. Moreover, the rise in cancer incidences will heighten the need for chemotherapy. For instance, the American Cancer Society Inc., a non-profit health organization based in the US, predicts that by 2023, there will be 1.9 million new cancer diagnoses in the US, a rise from the 1.8 million new cases diagnosed in 2020. There are projections of 609,820 cancer-related fatalities in the US in 2023, whilst 606,520 cancer deaths were projected for 2020. Thus, the escalating incidences of cancer are fueling the growth of the chemotherapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9219&type=smp

How Is the Chemotherapy Market Segments Structured?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

What Strategic Trends Are Transforming the Chemotherapy Market?

Leading corporations in the chemotherapy market are concentrating on bringing forth innovative products such as chemotherapy infusion pumps to solidify their position. These infusion pumps serve as a conduit for chemo drugs directly into the patient’s bloodstream via an IV line. It aids in the regulation of chemotherapy delivery in a controlled fashion, permitting a consistent, gradual introduction of drugs into the body. A case in point, in March 2022, Shanghai MicroPort Lifesciences Co. Ltd., a medical technology developer and manufacturer based in China, got the green light from the National Medical Products Administration (NMPA) of China to market its AutoEx Chemotherapy Infusion Pump. The pump is a design for the continuous or sporadic infusion of chemotherapy treatments for patients battling malignancies. Its function is to uphold the optimum drug concentration in the blood, thereby boosting the efficacy of the cancer treatment while minimizing side effects. The infusion pump boasts of a dual CPU control system and dual power supply, allowing the precise delivery of drugs and improving the patient’s comfort and safety during chemotherapy treatments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Which Global Regions Offer the Highest Growth in the Chemotherapy Market?

North America was the largest region in the chemotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9219

This Report Delivers Insight On:

1. How big is the chemotherapy market, and how is it changing globally?

2. Who are the major companies in the chemotherapy market, and how are they performing?

3. What are the key opportunities and risks in the chemotherapy market right now?

4. Which products or customer segments are growing the most in the chemotherapy market?

5. What factors are helping or slowing down the growth of the chemotherapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theChemotherapy Market?

The growth of the chemotherapy market is likely to be boosted by the surging prevalence of cancer. When certain cells in the body begin to multiply uncontrollably and metastasize, we refer to it as cancer. Chemotherapy utilizes potent chemicals, either in combination or individually, to treat cancer by eradicating rapidly multiplying cancer cells. The rising incidence of cancer will correspondingly amplify the need for chemotherapy. For example, the American Cancer Society Inc., a non-profit health organization based in the US, predicts 1.9 million new cancer diagnoses in the country in 2023, a rise from 1.8 million new cases in 2020. Additionally, it is predicted that 609,820 cancer-related fatalities will occur in the US in 2023, up from an estimated 606,520 deaths in 2020. Hence, the escalating prevalence of cancer is fueling the demand in the chemotherapy market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

How Has the Chemotherapy Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

In recent times, the chemotherapy market has seen swift expansion. The market, which stood at $34 billion in 2024, is now projected to rise to $37.78 billion in 2025, signifying an incredible compound annual growth rate (CAGR) of 11.1%. This extraordinary growth during the past years is a result of several factors including increasing incidence of cancer, advancements in diagnostic methods, innovative drug development, active clinical trials, enhanced healthcare accessibility, and awareness drives.

It is anticipated that the chemotherapy market will witness significant expansion in the upcoming years, with expected growth to $62.22 billion in 2029, showcasing a compound annual growth rate (CAGR) of 13.3%. The projected growth during the forecast period is due to factors such as the integration of immunotherapy, adoption of biosimilars, the expansion of emerging markets, genomic profiling, advancements in supportive care, and regulatory facilitation. Leading trends during the forecast period encompass digital health solutions, personalized treatment, ongoing oncology research, the use of artificial intelligence (AI), developments in nanotechnology, and home-based chemotherapy administration.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9219

What Key Market Trends and Innovations Are Shaping the Future of theChemotherapy Industry?

The key players in the chemotherapy market are ensuring their competitive advantage by developing innovative technologies such as chemotherapy infusion pumps. These devices help deliver chemotherapy drugs directly into a patient’s bloodstream via an intravenous line. They provide a secure and controlled method to slowly introduce the drugs into the body. For instance, in March 2022, the China-based medical technology developer Shanghai MicroPort Lifesciences Co. Ltd., received approval for marketing the AutoEx Chemotherapy Infusion Pump from China’s National Medical Products Administration (NMPA). The AutoEx pump is engineered for either continuous or intermittent infusion of chemotherapy drugs in cancer patients. It is designed to keep an optimum concentration of the drug in the bloodstream to enhance cancer treatment efficacy while minimizing side effects. The device incorporates a dual CPU control system and standby power supply, ensuring precise drug delivery. This feature makes the pump more comfortable and safer for patients during chemotherapy treatment.

Which Companies Are Leading the Charge in Expanding theChemotherapy Market Growth?

Major companies operating in the chemotherapy market include GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

How is the Global Chemotherapy Market Segemented?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=9219&type=smpGlobal Chemotherapy Market, Global Chemotherapy Market Report, Global Chemotherapy Market Trends, Global Chemotherapy Market Size

Browse Through More Reports Similar to the Gobal Chemotherapy Maret 2025, By The Business Research Company:

Lung Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Monoclonal Antibodies (MAs) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-global-market-report

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the chemotherapy market grown in recent years?

In recent times, there has been a swift expansion in the size of the chemotherapy market. The market value, which stands at $34 billion in 2024, is projected to rise to $37.78 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.1%. Factors contributing to this upward trend in the historic period include heightened incidences of cancer, improvements in cancer identification methods, novel drug development, increased clinical trial activity, broader access to healthcare services, and public awareness campaigns.

How is the chemotherapy market size expected to evolve during the forecast period?

The market size of chemotherapy is predicted to experience a swift expansion in the forthcoming years. The market is projected to reach $62.22 billion by 2029, undergoing a compound annual growth rate (CAGR) of 13.3%. The anticipated growth throughout the forecast period is primarily due to factors such as incorporation of immunotherapy, endorsement of biosimilars, proliferation in emerging markets, progression in genomic profiling, advancements in supportive care, and regulatory facilitation. The key trends during the forecast period are likely to be digital health solutions, individualized treatment, ongoing research in oncology, incorporation of artificial intelligence (AI), progress in nanotechnology and administration of chemotherapy at home.

Get your chemotherapy market report here!

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Which key drivers are propelling the chemotherapy market’s growth?

The chemotherapy market’s growth is anticipated to be fueled by the rising incidence of cancer. Cancer is a condition characterized by uncontrolled and rampant growth of a few body cells, which eventually spread to other parts of the body. Chemotherapy, which employs potent chemicals individually or in combination to kill rapidly growing cancer cells, is a common treatment for this disease. As the incidence of cancer increases, so will the demand for chemotherapy. The American Cancer Society Inc., a non-profit health organization in the US, predicts that there will be 1.9 million new cancer diagnoses in the US in 2023, up from 1.8 million in 2020. The US is also expected to see 609,820 cancer-related deaths in 2023, a rise from the predicted 606,520 cancer deaths in 2020. Consequently, the increasing incidence of cancer is acting as a catalyst for the chemotherapy market’s expansion.

What are the market segments in the chemotherapy industry?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

Which leading companies are shaping the growth of the chemotherapy market?

Major companies operating in the chemotherapy market include GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

What key trends are currently impacting the chemotherapy market’s development?

The leading firms in the chemotherapy market are strategizing for a competitive advantage by launching inventive products like chemotherapy infusion pumps. These are special devices that deliver chemotherapy medicines straight into the blood circulation via an IV line, and facilitate a controlled, slow and steady drug infusion. For example, in March 2022, Shanghai MicroPort Lifesciences Co. Ltd., a medical technology developer and manufacturer from China, acquired marketing permission from the National Medical Products Administration (NMPA) of China for their AutoEx Chemotherapy Infusion Pump. This pump is intended for either continuous or intermittent infusion of chemotherapy drugs for cancer patients. It is designed to ensure an optimal drug concentration in the bloodstream, thereby improving the efficacy of cancer therapy and minimizing side-effects. The device is equipped with a dual CPU control system and a dual power source, leading to highly accurate drug delivery. This contributes to enhanced comfort and safety of patients during chemotherapy.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9219

Which geographic areas are influencing the growth of the chemotherapy market?

North America was the largest region in the chemotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Lung Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Monoclonal Antibodies (MAs) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-global-market-report

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Rapidly is the Chemotherapy Market Expected to Expand Between 2025 and 2034 Based on Current Trends?

The market for chemotherapy has seen swift expansion in the recent past. Its growth is forecasted to surge from a worth of $34 billion in 2024 to $37.78 billion in 2025, with a compound annual growth rate (CAGR) of 11.1%. This growth during the historical period is presumably due to escalating cancer incidences, advancements in cancer diagnostic techniques, innovative strides in drug development, active clinical trials, accessibility to healthcare facilities, and heightened awareness campaigns.

In the ensuing years, the chemotherapy market size is predicted to experience swift expansion. It’s projected to reach a total worth of $62.22 billion in 2029, growing at a compound annual growth rate (CAGR) of 13.3%. The anticipated increment during the forecasting phase can be linked to the assimilation of immunotherapy, acceptance of biosimilars, increased growth in emerging markets, genomic profiling, progress in supportive care, and regulatory assistance. Noteworthy trends expected during the forecast period are the incorporation of digital health solutions, personalised medicine, persistent research in oncology, the use of artificial intelligence (ai), advancements in nanotechnology, and administration of chemotherapy at patients’ homes.

What Combination of Drivers Is Leading to Accelerated Growth in the chemotherapy Market?

The escalation in cases of cancer is anticipated to fuel the expansion of the chemotherapy market. Cancer is a condition where certain cells in the body proliferate uncontrollably and metastasize to other areas. Chemotherapy uses potent drugs, either individually or in combination, to treat cancer by eradicating fast-growing cancer cells. As the occurrence of cancer rises, so will the demand for chemotherapy. For example, the American Cancer Society Inc., a non-profit health organization based in the US, forecasts that there will be 1.9 million new cancer cases in 2023, up from 1.8 million in 2020. Furthermore, it is projected that in the United States, 609,820 people will die from cancer in 2023 compared to the 606,520 anticipated fatalities in 2020. Consequently, the rise in cancer cases is a significant factor driving the growth of the chemotherapy market.

Explore Comprehensive Insights Into The Global Chemotherapy Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

Which Key Players Are Shaping the Future of the Chemotherapy Market?

Major companies operating in the chemotherapy market include:

• GlaxoSmithKline plc_x000D_

• Eli Lilly and Company_x000D_

• F. Hoffmann-La Roche Ltd._x000D_

• Novartis AG_x000D_

• Pfizer Inc._x000D_

How Are the Latest Trends Influencing the Growth of the Chemotherapy Market?

Leading businesses within the chemotherapy market are looking at strategic innovations such as chemotherapy infusion pumps to stay competitive. Essentially, these are devices that inject chemotherapy treatments straight into a patient’s bloodstream via an intravenous line, permitting regulated control over the infusion rate of the drugs into the body. A case in point, Shanghai MicroPort Lifesciences Co. Ltd., a healthcare tech company based in China, was given the green light to market their AutoEx Chemotherapy Infusion Pump by China’s National Medical Products Administration (NMPA) in March 2022. The AutoEx pump has been specifically engineered for the continuous or periodical infusion of chemotherapy medications into patients afflicted with cancerous conditions. The device, which is equipped with a dual CPU control system and dual power functionality, aiming at sustaining an ideal drug concentration in the bloodstream to boost the efficacy of cancer treatments and decrease the potential side effects. Simultaneously, its design enhances patient comfort and ensures safety during chemotherapy sessions.

Secure Your Global Chemotherapy Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

How Are Key Segments Defining the Competitive Landscape of the Chemotherapy Market?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

What Regions Are At the Forefront of Chemotherapy Market Expansion?

North America was the largest region in the chemotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Is the Chemotherapy Market Classified and Defined in Market Analysis?

Chemotherapy refers to a treatment using drugs or medicines that kill the fast-growing cells in the body by using powerful chemicals. The drugs can be used in combination or alone for the treatment of cancer. They are used to treat cancer, as cancer cells grow at a fast rate.

Browse Through More Similar Reports By The Business Research Company:

Lung Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Monoclonal Antibodies (MAs) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-global-market-report

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: